from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0936/pstA2

LFCtreatmentdescriptionclass of inhibitor

-1.262

Amikacinug/mL Amikacintranslation

-0.311

Cap5-10ug/mL Capreomycintranslation

-0.381

Rox10-50 ug/mL Roxithromycintranslation

-0.752

SM2-5 ug/mL Streptomycintranslation

-2.399

Tet5-10 ug/mL Tetracyclinetranslation

0.130

Rif0.2-5ug/mL Rifampicintranscription

0.381

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.705

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.011

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.330

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.819

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.204

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.542

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.534

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.692

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.066

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.798

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.314

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.471

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.273

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.027

KCN5-20 ug/mL Potassium cyaniderespiration

-0.759

NaN30.2-2 mM Sodium aziderespiration

1.071

Nigericin50 uM Nigericinrespiration

-0.524

TRC10-150 ug/mL Triclosanrespiration

-1.722

TRZ10-25 ug/mL Thioridazinerespiration

-2.301

Valinomycin0.5-10 uM Valinomycinrespiration

-0.067

ZnSO42 mM ZnSO4respiration

-1.225

menadione6-10 ug/mL Menadionerespiration

-0.022

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.405

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.898

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.268

NRP_1Non-replicating persistence stage 1dosRassociated

0.711

Amp0.2mg/mL AmpicillincellWall

0.617

Cephalexin20-100 ug/mL CephalexincellWall

0.456

Cerulenin0.32-5 ug/mL CerulenincellWall

0.524

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.718

EMB10-20 ug/mL EthambutolcellWall

0.159

Eta12-40 ug/mL EthionamidecellWall

0.316

INH0.2-0.4 ug/mL IsoniazidcellWall

0.176

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.253

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.047

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.028

BZA0.12 mg/mL BenzamidearomaticAmides

0.878

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.369

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.366

H2O24 mM hydrogen peroxideDNAdamaging

0.913

Levo10 ug/mL LevofloxacinDNAdamaging

0.469

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.029

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.073

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.373

UVUV-irradiationDNAdamaging

-0.728

ARP41-4 ug/mL Antitubercular compound ARP4?

0.181

Antimycin12.5-50 ug/mL Antimycin A?

0.419

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.335

PA_110-50 ug/mL Antitubercular compound PA-1?

0.279

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.050

PA8240.2-2 ug/mL PA-824?

-0.965

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.099

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.392

Verapamil50 uM Verapamil?

0.707

mercaptoethanol2 mM 2-Mercaptoethanol?

0.969

methoxatin10-20 ug/mL Methoxatin?